Join Growin Stock Community!

Neogen corporationNEOG.US Overview

US StockHealthcare
(No presentation for NEOG)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NEOG AI Insights

NEOG Overall Performance

NEOG AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NEOG Recent Performance

-2.05%

Neogen corporation

0.05%

Avg of Sector

-0.31%

S&P500

NEOG PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NEOG Key Information

NEOG Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NEOG Profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Price of NEOG

NEOG FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NEOG Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.77
PE Ratio (TTM)
-
Forward PE
131.18
PS Ratio (TTM)
2.77
PB Ratio
1.17
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
45.98%
Net Margin
-68.47%
Revenue Growth (YoY)
-3.67%
Profit Growth (YoY)
-9.77%
3-Year Revenue Growth
-0.78%
3-Year Profit Growth
-1.77%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.77
PE Ratio (TTM)
-
Forward PE
131.18
PS Ratio (TTM)
2.77
PB Ratio
1.17
Price-to-FCF
-
Gross Margin
45.98%
Net Margin
-68.47%
Revenue Growth (YoY)
-3.67%
Profit Growth (YoY)
-9.77%
3-Year Revenue Growth
-0.78%
3-Year Profit Growth
-1.77%

  • When is NEOG's latest earnings report released?

    The most recent financial report for Neogen corporation (NEOG) covers the period of 2026Q2 and was published on 2025/11/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NEOG's short-term business performance and financial health. For the latest updates on NEOG's earnings releases, visit this page regularly.

  • What is the operating profit of NEOG?

    According to the latest financial report, Neogen corporation (NEOG) reported an Operating Profit of -5.38M with an Operating Margin of -2.39% this period, representing a growth of 98.82% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is NEOG's revenue growth?

    In the latest financial report, Neogen corporation (NEOG) announced revenue of 224.69M, with a Year-Over-Year growth rate of -2.84%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does NEOG have?

    At the end of the period, Neogen corporation (NEOG) held Total Cash and Cash Equivalents of 145.34M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does NEOG go with three margins increasing?

    In the latest report, Neogen corporation (NEOG) did not achieve the “three margins increasing” benchmark, with a gross margin of 47.5%%, operating margin of -2.39%%, and net margin of -7.1%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NEOG's profit trajectory and future growth potential.

  • Is NEOG's EPS continuing to grow?

    According to the past four quarterly reports, Neogen corporation (NEOG)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.07. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of NEOG?

    Neogen corporation (NEOG)'s Free Cash Flow (FCF) for the period is 7.78M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 66.34% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of NEOG?

    The latest valuation data shows Neogen corporation (NEOG) has a Price-To-Earnings (PE) ratio of -3.5 and a Price/Earnings-To-Growth (PEG) ratio of 0.14. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.